OTC Decongestants (Oral Phenylephrine)

Case Update:  On October 9, 2024, following briefing and argument, the Court issued an order dismissing the consolidated proceedings.  The cases are currently inactive pending a successful appeal. *** Phenylephrine (PE) is a common ingredient found in most over-the-counter (OTC)…

Allergan, BIOCELL Implants

Case Updates: Since Defendants’ motion to dismiss was partially denied, the parties have engaged in extensive discovery exchanges and disputes, involving the exchange of millions of documents. On October 25, 2022, Special Master Judge Dickson (Ret.) issued an order requiring…

Essentia Health

FeganScott filed a class action lawsuit on behalf of individuals and their children affected by improper vaccine storage. On April 6, 2020, Essentia Health notified approximately 50,000 patients, allegedly in North Dakota and Minnesota, that their medications or vaccines might have been…

Zantac

FeganScott filed a national class action lawsuit claiming that pharmaceutical giants GlaxoSmithKline, Pfizer, Boehringer Ingelheim, and Sanofi, failed to warn consumers that the heartburn medication, Zantac, produces a clinically proven carcinogen in the body at levels far beyond what regulators…